1 |
Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.
|
2 |
Siegel RL,Miller KD,Jemal A.Cancer Statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
|
3 |
Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
|
4 |
Karimi P,Islami F,Anandasabapathy S,et al.Gastric cancer:descriptive epidemiology,risk factors,screening,and prevention[J].Cancer Epidemiol Biomarkers Prev,2014,23(5):700-713.
|
5 |
Snyth EC,Nilsson M,Grabsch HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
|
6 |
Wei L,Sun J,Zhang N,et al.Noncoding RNAs in gastric cancer:implications for drug resistance[J].Mol Cancer,2020,19(1):62.
|
7 |
Biagioni A,Skalamera I,Peri S,et al.Update on gastric cancer treatments and gene therapies[J].Cancer Metastasis Rev,2019,38(3):537-548.
|
8 |
Pegtel DM,Gould SJ.Exosomes[J].Annu Rev Biochem,2019,88:487-514.
|
9 |
Xavier CPR,Caires HR,Barbosr MAG,et al.The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance[J].Cells,2020,9(5):1141.
|
10 |
Wang M,Ji S,Shao G,et al.Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients[J].Clin Transl Oncol,2018,20(7):906-911.
|
11 |
Wang H,Lu Z,Zhao X.Tumorigenesis,diagnosis,and therapeutic potential of exosomes in liver cancer[J].J Hematol Oncol,2019,12(1):133.
|
12 |
Huang T,Deng CX.Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers[J].Int J Biol Sci,2019,15(1):1-11.
|
13 |
Kopp F,Mendell JT.Functional Classification and Experimental Dissection of Long Noncoding RNAs[J].Cell,2018,172(3):393-407.
|
14 |
Bhan A,Soleimani M,Mandal SS.Long Noncoding RNA and Cancer:A New Paradigm[J].Cancer Res,2017,77(15):3965-3981.
|
15 |
Rathinasamy B,Velmurugan BK.Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals[J].Biomed Pharmacother,2018,102:242-248.
|
16 |
Zheng R,DU M,Wang X,et al.Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression[J].Mol Cancer,2018,17(1):143.
|
17 |
Chen C,Chen Q,Zhao Q,et al.Value of Combined Detection of Serum CEA,CA72-4,CA19-9,CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer[J].Ann Clin Lab Sci,2017,47(3):260-263.
|
18 |
Zhao R,Zhang Y,Zhang X,et al.Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer[J].Mol Cancer,2018,17(1):68.
|
19 |
Lin LY,Yang L,Zeng Q,et al.Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer[J].Mol Cancer,2018,17(1):84.
|
20 |
Li S,Zhang M,Zhang H,et al.Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer[J].Clin Chim Acta,2020,501:252-257.
|
21 |
Cai C,Zhang H,Zhu Y,et al.Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer[J].Onco Targets Ther,2019,12:10035-10041.
|
22 |
Zhou H,Shen W,Zou H,et al.Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer[J].J Int Med Res,2020,48(7): 300060520934297.
|
23 |
Zheng P,Zhang H,Gao H,et al.Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer[J].Onco Targets Ther,2020,13:4009-4018.
|
24 |
Xu H,Zhou J,Tang J,et al.Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer[J].J Clin Lab Anal,2020,34(8):e23323.
|
25 |
Guo X,Lv X,Ru Y,et al.Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer:A Multiphase Study[J].JAMA Surg,2020,155(7):572-579.
|
26 |
Cao S,Lin L,Xia X,et al.lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer[J].Mol Ther Nucleic Acids,2019,17:455-464.
|
27 |
Piao HY,Guo S,Wang Y,et al.Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI1[J].Clin Transl Oncol,2021,23(2):246-256.
|
28 |
Xin L,Wu Y,Liu C,et al.Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer[J].Mol Immunol,2021,140:196-205.
|
29 |
Wang L,Bo X,Yi X,et al.Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway[J].Cell Death Dis,2020,11(9):723.
|
30 |
Jin G,Zhang J,Cao T,et al.Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1[J].J Transl Med,2022,20(1):284.
|
31 |
Lu Y,Hou K,Li M,et al.Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter[J].Front Cell Dev Biol,2020,8:571297.
|
32 |
Piao HY,Guo S,Wang Y,et al.Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer[J].Onco Targets Ther,2020,13:1365-1374.
|
33 |
Wang Y,Jiang R,Zhao H,et al.TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies[J].Cell Biol Toxicol,2022.
|
34 |
Sasako M,Sakuramoto S,Katai H,et al.Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer[J].J Clin Oncol,2011,29(33):4387-4393.
|
35 |
Wang J,Lv B,Su Y,et al.Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis[J].Onco Targets Ther,2019,12:11325-11338.
|
36 |
Song Q,Lv X,Ru Y,et al.Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer:A multi-cohort,multi-phase study[J].EBioMedicine,2022,78:103971.
|